Key result
A 1-standard deviation increment in the intermuscular adipose tissue index at baseline was associated with an increased risk of type 2 diabetes incidence in normoglycemic adults.
Why the study?
Deposition of adipose tissue beneath muscle fascia rather than subcutaneously may precede insulin resistance and type 2 diabetes, prompting investigation into whether CT-derived adipose tissue biomarkers associate with incident diabetes in normoglycemic adults.
Does higher baseline intermuscular adipose tissue (IMAT) increase the incidence of type 2 diabetes in normoglycemic adults?
Cohort (n=1,744)
Yes
Does higher baseline intermuscular adipose tissue (IMAT) increase the incidence of type 2 diabetes in normoglycemic adults?
Answers are grounded in this paper and cite their sources.
Higher baseline intermuscular adipose tissue (IMAT) is independently associated with an increased risk of developing type 2 diabetes in normoglycemic adults, suggesting ectopic fat deposition precedes clinical insulin resistance.
BACKGROUND: Given the central role of skeletal muscles in glucose homeostasis, deposition of adipose depots beneath the fascia of muscles (versus subcutaneous adipose tissue [SAT]) may precede insulin resistance and type 2 diabetes (T2D) incidence. This study was aimed to investigate the associations between computed tomography (CT)-derived biomarkers for adipose tissue and T2D incidence in normoglycemic adults. METHODS AND FINDINGS: This study was a population-based multiethnic retrospective cohort of 1,744 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) with normoglycemia (baseline fasting plasma glucose [FPG] less than 100 mg/dL) from 6 United States of America communities. Participants were followed from April 2010 and January 2012 to December 2017, for a median of 7 years. The intermuscular adipose tissue (IMAT) and SAT areas were measured in baseline chest CT exams and were corrected by height squared (SAT and IMAT indices) using a predefined measurement protocol. T2D incidence, as the main outcome, was based on follow-up FPG, review of hospital records, or self-reported physician diagnoses. Participants' mean age was 69 ± 9 years at baseline, and 977 (56.0%) were women. Over a median of 7 years, 103 (5.9%) participants were diagnosed with T2D, and 147 (8.4%) participants died. The IMAT index (hazard ratio [HR]: 1.27 [95% confidence interval [CI]: 1.15-1.41] per 1-standard deviation [SD] increment) and the SAT index (HR: 1.43 [95% CI: 1.16-1.77] per 1-SD increment) at baseline were associated with T2D incidence over the follow-up. The associations of the IMAT and SAT indices with T2D incidence were attenuated after adjustment for body mass index (BMI) and waist circumference, with HRs of 1.23 (95% CI: 1.09-1.38) and 1.29 (95% CI: 0.96-1.74) per 1-SD increment, respectively. The limitations of this study include unmeasured residual confounders and one-time measurement of adipose tissue biomarkers. CONCLUSIONS: In this study, we observed an association between IMAT at baseline and T2D incidence over the follow-up. This study suggests the potential role of intermuscular adipose depots in the pathophysiology of T2D. TRIAL REGISTRATION: ClinicalTrials.gov NCT00005487.
No takes yet. Share an insight, caveat, or question.
Pishgar et al. (2021) conducted a cohort in Type 2 diabetes (n=1,744). Intermuscular adipose tissue (IMAT) index vs. Lower IMAT index was evaluated on Type 2 diabetes incidence (HR 1.27, 95% CI 1.15-1.41, p=<0.001). A 1-standard deviation increment in the intermuscular adipose tissue index at baseline was associated with an increased risk of type 2 diabetes incidence in normoglycemic adults.
Synapse has enriched 10 related papers. Consider them for comparative context: